KR30031, identified by its CAS number 205535-74-6, is a chemical compound that belongs to a specific class of substances often utilized in various industrial applications. While detailed characteristics such as its molecular structure, physical properties, and specific uses may vary, compounds like KR30031 typically exhibit unique reactivity profiles and solubility characteristics that make them suitable for particular applications, such as in pharmaceuticals, agrochemicals, or materials science. The compound may possess functional groups that influence its chemical behavior, stability, and interaction with other substances. Additionally, safety data sheets (SDS) would provide essential information regarding its handling, toxicity, and environmental impact. For precise details regarding its characteristics, including molecular weight, boiling point, and specific applications, consulting specialized chemical databases or literature is recommended, as these resources can provide comprehensive and up-to-date information.

KR30031 is a novel P-glycoprotein inhibitor with potential anticancer activity. KR30031 is a verapamil analog with fewer cardiovascular effects. The ability of KR-30031 to reduce this efflux transport is equal to that of verapamil, a well-known P-glycoprotein inhibitor. The bioavailability of paclitaxel could be enhanced by coadministration of a P-glycoprotein inhibitor, KR-30031.

KR30031

205535-74-6: KR30031, identified by its CAS number 205535-74-6, is a chemical compound that belongs to a specific class of substances often utilized in various industrial applications. While detailed characteristics such as its molecular structure, physical properties, and specific uses may vary, compounds like KR30031 typically exhibit unique reactivity profiles and solubility characteristics that make them suitable for particular applications, such as in pharmaceuticals, agrochemicals, or materials science. The compound may possess functional groups that influence its chemical behavior, stability, and interaction with other substances. Additionally, safety data sheets (SDS) would provide essential information regarding its handling, toxicity, and environmental impact. For precise details regarding its characteristics, including molecular weight, boiling point, and specific applications, consulting specialized chemical databases or literature is recommended, as these resources can provide comprehensive and up-to-date information.

<p>KR30031 is a novel verapamil-like P-glycoprotein inhibitor with fewer heart side-effects, potentially boosting paclitaxel's efficacy.</p>

CAS 205535-74-6

KR30031

KR30031

Ref: TM-T69956